The Injective blockchain community has delivered a decisive mandate for enhanced scarcity, voting 99.89% to implement the “INJ Supply Squeeze.” This new mechanism, formalized as proposal IIP-617, permanently accelerates the rate at which the native INJ token is removed from circulation. By doubling down on its deflationary design, Injective aims to structurally bolster tokenomics and position INJ as a long-term store of value aligned with ecosystem expansion, though its market price has yet to reflect these aggressive supply reductions.
about Injective Doubles Deflation with INJ Supply Squeeze VoteInjective
0 posts last weekShiba Inu Technical Analysis: Weak Until Cycle End
Popular technical analyst Charting Guy has delivered a sobering assessment of Shiba Inu (SHIB), classifying the meme token among ‘Bad Looking Charts’ and projecting it will remain weak and choppy until the final stages of the current crypto cycle. His October 2025 analysis shows SHIB trading below critical Fibonacci resistance levels while major cryptocurrencies like Bitcoin and Ethereum demonstrate stronger technical structures, suggesting a narrow, quality-focused market that may delay any significant SHIB breakout.
about Shiba Inu Technical Analysis: Weak Until Cycle EndTria Raises $12M for Self-Custodial Neobank Serving Humans & AI
Tria has secured $12 million in pre-seed and strategic funding to build what could be the missing link in crypto adoption: a global self-custodial neobank designed for both human users and autonomous AI agents. Backed by prominent investors including P2 Ventures, Aptos, and executives from Polygon and Ethereum Foundation, Tria aims to solve crypto’s fundamental usability gap by enabling seamless spending, trading, and earning from a single self-custodial balance—eliminating traditional complexities like gas fees, bridges, and seed phrases that have hindered mainstream adoption.
about Tria Raises $12M for Self-Custodial Neobank Serving Humans & AITria Raises $12M to Build Self-Custodial Neobank for Humans and AI
Tria has secured $12 million in pre-seed and strategic funding to develop a revolutionary self-custodial neobank that serves both human users and AI agents, bridging the critical gap between traditional finance and Web3. The platform eliminates intermediaries while maintaining user custody, promising fee-free global transactions across multiple chains with backing from major crypto investors including P2 Ventures, Aptos, and executives from Polygon and Ethereum Foundation.
about Tria Raises $12M to Build Self-Custodial Neobank for Humans and AIInjective Launches Onchain Pre-IPO Perpetuals for OpenAI
Injective Protocol has launched onchain pre-IPO perpetual markets, enabling global investors to trade synthetic versions of major private companies like OpenAI. The new offering provides up to 5x leveraged exposure to private company valuations through decentralized infrastructure, representing a significant alternative to centralized pre-IPO products currently available in the market.
about Injective Launches Onchain Pre-IPO Perpetuals for OpenAIInjective (INJ) Price Analysis: Resistance at $14.34, 2025 Outlook
Injective (INJ) faces a critical resistance test at $14.34 as analysts project mixed but generally optimistic long-term prospects. The token’s ability to break through this technical barrier could determine its trajectory toward higher price targets. Current market activity shows declining volume amid short-term bearish pressure.
about Injective (INJ) Price Analysis: Resistance at $14.34, 2025 OutlookINJ Nears $16 Breakout as Wallet Growth Hits Record High
Injective (INJ) is holding near the $16 breakout level, with resistance targets at $20, $22, and $27 if the upward momentum continues. Analysts highlight a bullish ascending triangle pattern and potential for higher highs, contingent on holding above key support levels. Wallet growth has surged past 4,000, reflecting increasing adoption, while the CBOE’s SEC filing for a staked INJ ETF underscores institutional interest. A short-term pullback to $14.2–$14.5 could offer a buying opportunity before another leg up. The network’s expanding user base and regulatory progress position INJ for further gains.
about INJ Nears $16 Breakout as Wallet Growth Hits Record HighAltcoins Lead Crypto Rebound Amid Trump Trade War Fallout
The cryptocurrency market is showing signs of recovery, with altcoins like XRP and Ethereum leading the charge after a week dominated by losses. XRP and Ethereum climbed 4.5% and 2.7%, respectively, as the market rebounded from the impact of President Trump’s new tariffs, which ranged from 10% to 41% on key trading partners. Prediction markets now suggest a 64% chance of an XRP ETF approval before Litecoin and a 54.4% likelihood of Ethereum setting a new all-time high this year. Ethereum-based DeFi protocol Ethena surged 10.8%, while Stellar and Injective also posted significant gains. Despite the daily uptick, most cryptocurrencies remain in the red over the past week, reflecting broader market uncertainty triggered by the trade war and its ripple effects on traditional markets like the S&P 500.
about Altcoins Lead Crypto Rebound Amid Trump Trade War FalloutTrump Tariffs Trigger $600M Crypto Crash, BTC Hits 3-Week Low
On August 1, President Trump’s new tariffs—including a 10% levy on imports from non-exempt nations and a hike to 35% on Canadian goods—triggered a sharp crypto market correction. Bitcoin fell to $114,400 (down 3%), while altcoins like ETH and XRP dropped 6%, with some losing double digits. Over 160,000 leveraged traders were liquidated, totaling $650 million in losses ($600M from longs). The crypto market cap shed $150 billion, dropping to $3.82 trillion. This mirrors April’s tariff-induced crash, where BTC lost $25,000 in days. Critics, like The Kobeissi Letter, argue the trade war has ‘lost all credibility’ due to abrupt policy shifts.
about Trump Tariffs Trigger $600M Crypto Crash, BTC Hits 3-Week LowCboe Files to List Staked Injective ETF, Expanding Crypto Offerings
The Cboe has submitted a 19b-4 filing to list Canary Capital’s proposed staked Injective ETF, following the firm’s S-1 application with the SEC in July. If approved, this would be the third staked crypto ETF in the U.S., joining Solana and Ether-based funds. The ETF aims to generate staking rewards by leveraging an approved staking platform, further expanding regulated crypto investment options for U.S. investors. This development underscores the growing institutional interest in crypto staking and ETF products.
about Cboe Files to List Staked Injective ETF, Expanding Crypto OfferingsInjective (INJ) Hits 5-Month High Amid Bullish Breakout
Injective (INJ) has reached a five-month peak at $16.35, breaking past a crucial resistance level and signaling a potential bullish reversal. Analysts like Crypto Rand and Ali Martinez highlight key patterns—such as an ascending triangle and inverse Head and Shoulders—that could propel INJ to $25 or even $41 if resistance levels hold. Despite a recent 10% intraday pullback, the token’s strong performance (up 40% since June) and its status as the Layer-1 leader in code commits (36,500 in 365 days) bolster optimism. However, a drop below $12 could invalidate the bullish setup, pushing INJ toward $10 support. Currently trading at $14.70, INJ’s next moves hinge on reclaiming $15-$16 resistance.
about Injective (INJ) Hits 5-Month High Amid Bullish BreakoutCanary Capital Files First Staked INJ ETF, INJ Jumps 8%
Canary Capital has submitted a filing to the SEC for the Canary Staked INJ ETF, which would track INJ’s price while distributing staking rewards to shareholders. The ETF aims to simplify staking by automating rewards through a regulated financial product, catering to growing institutional and retail demand. Following the announcement, INJ surged 8%, hitting a monthly high of $14.40, with daily trading volume exceeding $226 million. The filing follows Delaware trust registration and joins pending ETF applications for XRP, TRON, Litecoin, Hedera, and PENGU. Regulatory uncertainty remains as the SEC has yet to approve staking-based ETFs, though recent legislative developments like the GENIUS and CLARITY Acts could influence the outcome.
about Canary Capital Files First Staked INJ ETF, INJ Jumps 8%